Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CRSP
CRSP logo

CRSP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CRSP News

Cathie Wood Shifts AI Investment Focus to Healthcare

9h agoNewsfilter

Cathie Wood's ARK Divests Meta Shares to Invest in This AI Stock.

4d agoBarron's

Cathie Wood's ARK Divests Meta Shares to Invest in This AI Stock.

4d agoBarron's

CRISPR THERAPEUTICS AG: LEERINK PARTNERS REDUCES TARGET PRICE FROM $74 TO $60

5d agomoomoo

AvaíBio Initiates α-Klotho Cell Bank Creation

6d agoPRnewswire

AvaíBio Initiates Master Cell Bank for α-Klotho Production

6d agoNewsfilter

CRISPR Therapeutics: Financing and Future Prospects

Mar 23 2026Fool

CRISPR Raises $600 Million, Stock Price Pressured

Mar 23 2026NASDAQ.COM

CRISPR Therapeutics Faces Challenges and Opportunities Ahead

Mar 20 2026Fool

CRISPR Therapeutics Faces Challenges and Opportunities Ahead

Mar 20 2026NASDAQ.COM

Analysis of ARKK ETF's 52-Week Price Fluctuations

Mar 19 2026NASDAQ.COM

CRISPR Therapeutics Prices $550 Million Convertible Notes Offering

Mar 11 2026NASDAQ.COM

CRISPR Therapeutics Prices $550M Convertible Notes Offering

Mar 11 2026seekingalpha

ARK Invest Increases Stake in CRISPR Therapeutics Amid Market Volatility

Mar 11 2026seekingalpha

Three Stocks Poised for Decade-Long Gains

Mar 11 2026Fool

CRISPR Therapeutics' Financing Plan Triggers Stock Price Drop

Mar 10 2026Fool